The 23-time Grand Slam champion says the medication is no shortcut, but a tool alongside exercise, diet and discipline ...

To make things a little less confusing, we’re here with all the info you need about popular weight loss med Mounjaro.

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Tennis champion Serena Williams has caused a stir after revealing that using GLP-1 medication has been key to her weight-loss ...

While tirzepatide has been on the market to treat type 2 diabetes under the name Mounjaro, Zepbound was just FDA approved for weight loss and most health insurances don’t cover it as a result ...

Treatment with tirzepatide led to significant weight loss in adults with obesity or overweight with weight-related comorbidities (excluding type 2 diabetes), according to results from the phase 3 ...

FMP, the University of Oxford, and the University of Birmingham have developed a novel imaging approach to track how popular ...

Clinical trials are currently underway to get tirzepatide FDA-approved as a weight-loss treatment. The drug is currently available under the brand name Mounjaro as a diabetes treatment, for which ...

A new study has found that tirzepatide, a weight-loss injection introduced in India this March, is more effective than semaglutide, a popular obesity drug already available in the country.

A week on from increases in the cost of Eli Lilly’s weight loss drug Mounjaro (tirzepatide), weight loss medication provider ...

Diabetes drug Tirzepatide, which is shown to be more effective than Wegovy and Ozempic, is likely to be approved by the Food and Drug Administration for weight loss in 2023 and is expected to be ...